RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

214 hedge funds and large institutions have $3.27B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 78 increasing their positions, 71 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
214
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$129M
Puts
$56.6M
Net Calls
Net Calls Change

Top Sellers

1 -$61.5M
2 -$47.5M
3 -$24.5M
4
Renaissance Technologies
Renaissance Technologies
New York
-$19.8M
5
BlackRock
BlackRock
New York
-$17.4M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$442M
2
$436M
3
$323M
4
$306M
5
$174M
6
$137M
7
$105M
8
$76.8M
9
$74.8M
10
$70.3M
11
$52.9M
12
$41.4M
13
$38.2M
14
$37.7M
15
$36M
16
$32.1M
17
$31M
18
$30.4M
19
$29.4M
20
$29.4M
21
$27.4M
22
$27.3M
23
$26.5M
24
$25.4M
25
$24.9M